Options
Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease
Fecha de emisión
2020
Autor(es)
Uddin M.S.
Kabir M.T.
Mamun A.A.
Rashid M.
Perveen A.
Ashraf G.M.
DOI
10.1016/j.intimp.2020.106479
Temas
Alzheimer's disease
Anti-inflammatory age...
Immune system
Neuroinflammation
Proinflammatory molec...
advanced glycation en...
amyloid beta protein
angiotensin 1 recepto...
antiinflammatory agen...
azeliragon
candesartan
cytokine
etanercept
gc 021109
granulocyte macrophag...
immunoglobulin
minocycline
neflamapimod
nonsteroid antiinflam...
nootropic agent
pioglitazone
prostaglandin synthas...
rosiglitazone
sargramostim
telmisartan
thalidomide
unclassified drug
Alzheimer disease
antiinflammatory acti...
cytokine release
disease exacerbation
drug targeting
human
insulin resistance
macroglia
mediator
microglia
mononuclear cell
nerve cell
nervous system inflam...
nonhuman
priority journal
protein expression
Review
signal transduction
Archivo(s)